Safety and Efficacy of Ubrogepant in Participants With Moderate to High Cardiovascular Risk

被引：0
|
作者：
Severt, Lawrence [1 ]
Silberstein, Stephen D. [2 ]
Blumenfeld, Andrew M. [3 ]
Lipton, Richard B. [4 ]
Lu, Kaifeng [1 ]
Yu, Sung Yun [1 ]
Hutchinson, Susan [5 ]
机构：
[1] Allergan Plc, Dublin, Ireland
[2] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[3] Headache Ctr Southern Calif, Irvine, CA USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Orange Cty Migraine & Headache Ctr, Irvine, CA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
107
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk
    Younk, Lisa M.
    Uhl, Lisa
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (06) : 753 - 763
  • [22] Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease A Randomized Clinical Trial
    Klug, Eric Q.
    Llerena, Sara
    Burgess, Lesley J.
    Fourie, Nyda
    Scott, Russell
    Vest, Jeff
    Caldwell, Kate
    Kallend, David
    Stein, Evan A.
    JAMA CARDIOLOGY, 2024,
  • [23] Clinical efficacy and safety of statins in managing cardiovascular risk
    Kapur, Navin K.
    Musunuru, Kiran
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (02) : 341 - 353
  • [24] A Comprehensive Review of the Mechanism, Efficacy, Safety, and Tolerability of Ubrogepant in the Treatment of Migraine
    Dighriri, Ibrahim M.
    Nazel, Shahad
    Alharthi, Aeshah M.
    Altowairqi, Nasreen A.
    Albariqi, Aqeel M.
    Tohari, Mona A.
    Alameer, Atheer A.
    Alsaran, Amjad K.
    Alshammari, Fares R.
    Almutairi, Naif F.
    Alsubaie, Fahad M.
    Alharbi, Turki A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [25] Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
    Lipton, Richard B.
    Dodick, David W.
    Goadsby, Peter J.
    Burstein, Rami
    Adams, Aubrey M.
    Lai, Jeff
    Yu, Sung Yun
    Finnegan, Michelle
    Kuang, Amy W.
    Trugman, Joel M.
    NEUROLOGY, 2022, 99 (17) : E1905 - E1915
  • [26] SAFETY AND EFFICACY OF MIPOMERSEN ADMINISTERED AS ADD-ON THERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND HIGH CARDIOVASCULAR RISK
    Cromwell, William C.
    Thomas, Gregory S.
    Boltje, Ingrid
    Chin, Wai
    Davidson, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E504 - E504
  • [27] Safety an Tolerability of Ubrogepant Following Intermittent, High Frequency Dosing
    Trugman, Joel M.
    Goadsby, Peter J.
    Tepper, Stewart J.
    Watkins, Paul
    Ayele, Girma
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Szegedi, Armin
    Jakate, Abhijeet
    NEUROLOGY, 2019, 92 (15)
  • [28] SHORT-TERM EFFICACY AND SAFETY OF HIGH-INTENSITY STATIN THERAPY IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
    Vorobyeva, M.
    Doronina, A.
    Villevalde, S.
    Kobalava, Z.
    JOURNAL OF HYPERTENSION, 2015, 33 : E190 - E190
  • [29] Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis
    Raichlin, Eugenia
    Prasad, Abhiram
    Mathew, Verghese
    Kent, Bailey
    Holmes, David R., Jr.
    Pumper, Geralyn M.
    Nelson, Rebecca E.
    Lerman, Lilach O.
    Lerman, Amir
    HYPERTENSION, 2008, 52 (03) : 522 - 528
  • [30] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
    Lim, Sian Yik
    WOMENS HEALTH, 2022, 18
12345